CP and neoplasm: In HGSC, spatial proteomics revealed that proteins associated with CP sensitivity in CP‐s tumours were primarily linked to the cell cycle, whereas resistant proteins in CP‐i tumours were enriched in metabolic pathways, indicating that CP effectiveness depends on tumour cells being in the proliferation stage of tumour.